Skip to content
FALANGAINVEST

Neuromesh

Kinematics and neural signal assessed together, inside the helmet.

Role in the group
Sensing stack for protective headgear · wholly owned by Falanga Invest Perton s.r.o.
Stage
Pre-prototype · €2 million seed round
Location
Bratislava · development at the University of Žilina
2€m
Size of the seed round
10€m
Pre-money valuation
6–8million
Ice-hockey helmets a year
5–7€m
Planned Series A

The market gap

The market measures the impact. Nobody reads the brain's response.

Every product in protective sports equipment today answers the same question — how hard was the blow. None answers the one that matters to a coach, a physician or a federation: what the brain was doing in the seconds afterwards.

Competition

Where the field stands today

Bearmind
EPFL spin-off · impact and kinematics
Prevent Biometrics
In-mouth impact sensing
Catapult
Athlete performance telemetry
WHOOP
Physiological load and recovery

Addressable volume

SegmentVolume
Ice-hockey helmets6–8 million a year
American football helmets5 million a year
Cycling helmets25 million a year
Wearable electronics marketUSD 150 billion

The competition tends to confirm the category rather than occupy this position: all of them are either kinematic or physiological, none neuromorphic.

The solution

Four layers inside the helmet

Sensors in the shell feed a neuromorphic module built on the CyberSwarm IGZO memristor platform. Impact data and the electrophysiological signal are fused and assessed on the device itself — no cloud, no latency and no dependence on connectivity in the arena.

Partner API

licensing of data and features

Analytics IP

signal fusion and assessment on the device

Neuromorphic module

memristor chip and signal acquisition

Sensors in the shell

6–10 sensors in the helmet

  • The differentiator is the fusion: kinematics plus neural signal, processed together in real time. Each on its own is known prior art; the combination is not.

  • The origin of the approach — CyberSwarm supplied the neuromorphic and algorithmic component to the brain-to-vehicle programme of a Japanese carmaker.

  • Neuromesh holds an exclusive multi-sport licence to that technology.

  • Beyond sport, the same stack targets industrial and military head protection.

The positioning is deliberate: the system monitors the neurological response. It is not a diagnostic medical device and it does not diagnose concussion.

The model

Licensed, not manufactured

Neuromesh follows the ARM model. It does not build a factory and does not sell helmets: it licenses the sensing stack to the companies that already make them and to the organisations that set the standards.

Equipment manufacturers

Licence fees from manufacturers of protective sports equipment.

Federations and leagues

Programme licences to federations and leagues that adopt the standard.

Partner platforms

API licences for partner platforms using the data layer.

Vertical expansion

Ice hockey first, then football, cycling and skiing; industrial safety after that.

Intellectual property

The patent portfolio

  • A priority application has been filed; the principal claim is the fusion of impact and neurological signal in wearable protective equipment.

  • The set of claims covers the system, the module, the method, the product, the use and the data platform — including multi-user aggregation via an API.

  • Extension is planned along the application verticals and through continuation applications — a portfolio is being built, not a single patent.

  • Development is carried out at the University of Žilina, which is paid for the work, with all resulting IP remaining with Neuromesh.

And what has not been validated

  • The patents are at application stage; an expert patentability and freedom-to-operate search is still missing.

  • Sub-licensing rights under the CyberSwarm licence need to be confirmed before any agreements with manufacturers.

  • The company is pre-prototype: the seed round funds the proof of concept and the first prototype.

  • The valuation and the path to a Series A are plans, not commitments.

Leadership

Who runs the project

Jan Imrišek
Chief Executive Officer
Mihai Raneti
Chief Technology Officer
Vazil Hudák
Executive Chairman
Helena Karlíková
Chair of the Board of Directors
Jozef Stümpel
Chief Operating Officer

Investment round

Seed of €2 million at a €10 million pre-money valuation

The seed round funds the proof of concept and the first prototype. Use of proceeds is set out below.

Use of proceedsAmount
Prototype and PoC€500,000
Core team€450,000
Certification€300,000
Testing€300,000
Marketing and ambassadors€200,000
Legal services€150,000
Reserve€100,000

Comparable valuations: Bearmind €12–15 million, Prevent Biometrics €20 million and above.

Ownership structure after the seed round

Founders and CyberSwarm
78.4%
Seed investors
16.6%
ESOP
5%
Number of shares
10,000
Series A, planned
€5–7 million at a valuation of €20–25 million

Overview

Key details

Company
Neuromesh, founded in May 2026 in Bratislava
Ownership
Wholly owned by Falanga Invest Perton s.r.o.
Licence
Exclusive multi-sport licence to the CyberSwarm neuromorphic technology
Development
Carried out at the University of Žilina, which is paid for the work; the resulting IP remains with Neuromesh
Seed round
€2 million at a €10 million pre-money valuation
Stage
Pre-prototype; the seed round funds the proof of concept and the first prototype

Pre-prototype stage: the seed round funds the proof of concept and the first prototype. The valuation and the path to a Series A are plans, not commitments.

The detail sits in the data room

Investment studies, contractual documentation and the data room are made available to qualified investors after an initial meeting and the signing of an NDA.

Request a consultation

Put the strength of global investment to work for your success.